Q3 EPS Estimates for Haemonetics Boosted by Zacks Research
Haemonetics Co. (NYSE:HAE – Free Report) – Equities researchers at Zacks Research boosted their Q3 2026 earnings per share estimates for Haemonetics in a research report issued on Monday, February 17th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will earn $1.33 per share for the quarter, up from their prior […]
Haemonetics Co. (NYSE:HAE – Free Report) – Equities researchers at Zacks Research boosted their Q3 2026 earnings per share estimates for Haemonetics in a research report issued on Monday, February 17th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will earn $1.33 per share for the quarter, up from their prior […]
